Stockreport

TC Biopharm executes second LOI to buy CAR-T therapies, shares up [Seeking Alpha]

TC BioPharm (Holdings) plc - American Depositary Shares  (TCBP) 
PDF pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors. CAR T-cell therapy [Read more]